Human t-Plasminogen Activator/tPA Alexa Fluor® 350-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # AF7449U

Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Ser36-Pro562
Accession # P00750
Specificity
Clonality
Host
Isotype
Applications
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
Background: t-Plasminogen Activator/tPA
PLAT (Plasminogen activator; also tPA/Tissue Plasminogen Activator) is a 64-69 kDa extracellular glycoprotein that belongs to the peptidase S1 family of enzymes. It is secreted by diverse cell types such as fibroblasts, endothelial cells and astrocytes. Unlike many other serine proteases, PLAT/tPA circulates as an active proenzyme. Following clot formation, both tPA and its substrate, plasminogen, bind to clot fibrin. Here, tPA converts plasminogen to plasmin, an enzyme that subsequently degrades the fibrin matrix of the clot. Plasmin also cleaves local tPA, generating a disulfide-linked, two-chain tPA isoform whose activity is potentiated 5- to10-fold relative to the uncleaved form. tPa also cleaves PDGF-CC and activates MMP-9, suggesting an expanded role in vascular remodeling. Human PLAT/tPA is secreted as a 530 amino acid (aa) single chain polypeptide (aa 33-562). Depending upon its source, aa 33-35 or 33-38 may be removed in the circulation. PLAT contains one N-terminal fibronectin type I region (aa 39-81), an EGD-like domain (aa 82-120), a two kringle structures (127-208; 215-296) and a peptidase S1 domain (311-561). Plasmin cleaves PLAT/tPA between Arg310-Ile311, generating an active disulfide-linked heterodimeric molecule that contains chains of 35 kDa and 33 kDa, respectively. There are multiple isoform variants. One contains a three aa substitution for aa 1-40 coupled to a deletion of aa 79-208, a second shows a Gly substitution for aa 39-85, and a third possesses a 23 aa substitution for aa 269-562. Two additional isoforms shows a His substitution for aa 54-134, and a 25 aa substitution for aa 269-562, respectively. Over aa 36-562, human PLAT shares 81% aa sequence identity with mouse PLAT.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional t-Plasminogen Activator/tPA Products
Product Specific Notices
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only